Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04528836
Title First-in-Human Study of the SHP2 Inhibitor BBP-398 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Navire Pharma Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Recruiting Duarte California 91010 United States Details
UC Irvine Health Active, not recruiting Orange California 92868 United States Details
UCLA Hematology/Oncology - Santa Monica Recruiting Santa Monica California 90404 United States Details
Sarah Cannon Research Institute Recruiting Denver Colorado 80218 United States Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77096 United States Details
NEXT Oncology Recruiting San Antonio Texas 78229 United States Details
Huntsman Cancer Institute Recruiting Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from for the field